⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8252887 | 1.00 | — | — | |
| SCHEMBL16923912 | 0.86 | CA2 (0.43) | — | |
| SCHEMBL10016030 | 0.86 | CA2 (0.43) | — | |
| SCHEMBL14345861 | 0.86 | CA2 (0.43) | — | |
| SCHEMBL8243242 | 0.84 | GPR84 (0.42) | — | |
| SCHEMBL14819876 | 0.84 | GPR84 (0.42) | — | |
| SCHEMBL2420397 | 0.83 | — | — | |
| SCHEMBL3867719 | 0.83 | — | — | |
| SCHEMBL24767730 | 0.82 | GPR84 (0.45) | — | |
| SCHEMBL15945288 | 0.82 | GPR84 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265115-A1 | Method for Preparing Glufosinate or Analogue Thereof | LIER CHEMICAL CO., LTD. (CN) | 2023-08-24 | — | — | US | disclosed |
| US-20230257405-A1 | METHOD FOR PREPARING GLUFOSINATE OR ANALOGUES THEREOF | LIER CHEMICAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-11680077-B2 | Preparation method for glufosinate | LIER CHEMICAL CO., LTD. (CN) | 2023-06-20 | — | — | US | disclosed |
| EP-4170347-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |
| EP-2928484-B1 | COMPOUNDS USEFUL IN THE TREATMENT AND/OR CARE OF THE SKIN, HAIR AND/OR MUCOUS MEMBRANES AND THEIR COSMETIC OR PHARMACEUTICAL COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2021-03-24 | — | — | EP | disclosed |
| US-9029359-B2 | Heteroaryl Btk inhibitors | BIOGEN IDEC MA, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-20120157442-A1 | HETEROARYL BTK INHIBITORS | SUNESIS PHARMACEUTICALS, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| WO-2011087740-A1 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | SCHERING CORPORATION (US) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011036074-A1 | AMINOQUINAZOLINE COMPOUNDS FOR COMBATING INVERTEBRATE PESTS | BASF SE (DE) | 2011-03-31 | — | — | WO | disclosed |
| US-20100331246-A1 | ESTER-BASED INSULIN PRODRUGS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2010-12-30 | — | — | US | disclosed |